<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology and pathogenesis of West Nile virus infection</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology and pathogenesis of West Nile virus infection</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology and pathogenesis of West Nile virus infection</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lyle R Petersen, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer Mitty, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 08, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>West Nile (WN) virus, a member of the Japanese encephalitis virus antigenic complex, was first isolated in a blood sample in a patient from the West Nile province of Uganda in 1937 [<a href="#rid1">1</a>]. This RNA virus was initially considered of minor public health importance [<a href="#rid2">2</a>]. It emerged from obscurity in 1999 when the first incursion of the virus into North America caused 62 cases of encephalitis and seven deaths in New York [<a href="#rid3">3</a>]. WN virus activity has now been detected in all 48 continental states and the District of Columbia [<a href="#rid4">4</a>]. WN virus causes both sporadic infection and outbreaks that may be associated with severe neurologic disease.</p><p>The epidemiology and pathogenesis of West Nile virus will be addressed here. The clinical manifestations, diagnosis, and treatment of infection are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1273.html" rel="external">"Clinical manifestations and diagnosis of West Nile virus infection"</a> and  <a class="medical medical_review" href="/z/d/html/1282.html" rel="external">"Treatment and prevention of West Nile virus infection"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>WN virus is one of the most widely distributed of all arboviruses with an extensive distribution in the Old World, throughout Africa, the Middle East, parts of Europe and the former Soviet Union, South Asia, and Australia [<a href="#rid5">5</a>]. The virus had not been detected in the Americas before the 1999 New York City outbreak. It is unknown how WN virus got to the United States. While initial phylogenetic studies suggested a Middle Eastern origin for the North American WN virus [<a href="#rid6">6,7</a>], subsequent analysis indicated that WN strains now circulating in Europe and Israel originated from the same independent location, probably North Africa [<a href="#rid8">8</a>]. WN virus is now considered endemic in North America [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Patterns of illness</span><span class="headingEndMark"> — </span>Since the first discovery of WN virus, infrequent human outbreaks were mostly reported in groups of soldiers, children, and healthy adults in Israel and Africa [<a href="#rid9">9-12</a>]. These outbreaks were associated with only minor illness in the majority of patients; some case fatalities were associated with increasing age. In one of the largest outbreaks reported, thousands of self-limited and relatively mild clinical cases, consisting of fever, rash, and polyarthralgias occurred in South Africa, resulting in an epidemic attack rate of 55 percent [<a href="#rid13">13</a>].</p><p>However, since the mid-1990s, outbreaks of WN virus infection associated with severe neurologic disease began to occur in North Africa (Algeria [1994, 1997], Tunisia [1997], Sudan [2002]); Europe (Romania [1996]); Russia (1999); Israel (2000); North America (United States [1999], Canada [2002]); and India (2011) [<a href="#rid4">4,14-19</a>]. In each of these outbreaks, the mortality among patients with meningitis and encephalitis was approximately 10 percent, and occurred more often in older patients. Since 2002, outbreaks have also occurred in multiple southern European countries, with annual epidemic cycles in some countries related to the spread of WN virus lineage 2 strains [<a href="#rid20">20-23</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Incidence in the United States</span><span class="headingEndMark"> — </span>Since 2000, the ArboNET national surveillance system has tracked WN virus in the United States, and WN virus is the leading cause of domestically acquired arboviral disease [<a href="#rid4">4,24</a>]. Most studies indicate that increased WN virus incidence is related to above-average temperatures, with variable impact of precipitation [<a href="#rid25">25,26</a>]. </p><p>Only about 1 to 2 percent of West Nile fever cases are reported [<a href="#rid24">24</a>] since most infected persons are asymptomatic, do not seek medical care for mild symptoms, or are not tested for WN virus. Thus, the most accurate trend data derive from monitoring cases of invasive neurologic disease [<a href="#rid27">27</a>]. The incidence of neuroinvasive disease varies considerably across the United States (<a class="graphic graphic_figure graphicRef90997" href="/z/d/graphic/90997.html" rel="external">figure 1</a>). Updated reports are available on the United States Centers for Disease Control and Prevention (CDC) <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fwestnile%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLEoyJA7FYK2lK6iGYL%2BtKnvUP95HNSq7yBXOFowdnyJ8&amp;TOPIC_ID=1304" target="_blank">website</a>.</p><p>From 1999 to 2019, a total of 51,801 confirmed and probable cases of WN virus disease, including 25,290 cases of neuroinvasive disease, were reported to the CDC from 48 states, the District of Columbia, and Puerto Rico [<a href="#rid28">28</a>]. Only 19 human cases of WN neuroinvasive disease were reported in the United States in 2000 and 64 in 2001. However, from 2002 to 2018, the number of reported neuroinvasive disease cases ranged from 386 to 2946; the three largest outbreaks occurred in 2002 (2946 cases), 2003 (2866 cases), and 2012 (2873 cases). </p><p>The large multistate outbreak in 2012 was widespread, with 43 states reporting a higher incidence of neuroinvasive disease in 2012 compared with the median for 2004 to 2011; more than half of these cases were reported from four states and 29 percent were reported from Texas alone [<a href="#rid29">29</a>]. The incidence rate of WN neuroinvasive disease in Dallas county was 7.30 per 100,000 residents in 2012, which was significantly higher than the largest previous Dallas County outbreak of 2.91 per 100,000 in 2006 [<a href="#rid30">30</a>]. The largest focal outbreak to date occurred in Maricopa County (Phoenix) in 2021, with more than 800 neuroinvasive disease cases reported as of November 2021 [<a href="#rid31">31</a>]. </p><p>However, serologic surveys and extrapolations from blood donor screening data indicate that neuroinvasive disease following infection is infrequent, with estimates ranging from 1 in 140 to 1 in 256 infections resulting in meningitis or encephalitis [<a href="#rid14">14,32-35</a>]. By extrapolation, the 24,657 cases of invasive neurologic disease reported in the United States through 2018 would imply that from 3.4 to 6.3 million persons have been infected. Serological surveys indicate that even in areas experiencing outbreaks, less than 10 percent of the population is infected with WN virus [<a href="#rid14">14,32,35,36</a>].</p><p>Human illnesses usually peak in late summer or early fall (<a class="graphic graphic_figure graphicRef90996" href="/z/d/graphic/90996.html" rel="external">figure 2</a>) [<a href="#rid4">4</a>]. As an example, cases peaked in late August during the 2012 outbreak in Dallas county, with 92 percent having illness onset during July through September [<a href="#rid30">30</a>]. The seasonal variation is because mosquitoes emerge in the spring in temperate climates, which begins viral amplification in the bird-mosquito-bird cycle. Viral amplification peaks in early fall; the risk of infection then decreases in humans when female mosquitoes begin diapause and infrequently bite. However, sporadic cases can occur throughout the year in southern states. </p><p class="headingAnchor" id="H5"><span class="h2">Incidence in Canada</span><span class="headingEndMark"> — </span>The epidemiology and ecology of WN virus in Canada reflect that of the northern United States. The virus is now endemic in all Canadian provinces. Through 2019, a total of 6423 patients with WN virus disease have been reported in Canada, ranging from 5 to 2401 annually [<a href="#rid37">37</a>]. The first human cases were reported in 2002, with 414 illnesses reported from Quebec and Ontario. The largest outbreaks occurred in 2003 (1488 cases) and 2007 (2401 cases).</p><p class="headingAnchor" id="H6"><span class="h2">Incidence in Latin America and the Caribbean</span><span class="headingEndMark"> — </span>WN virus was first detected south of the United States border in 2001, when a resident of the Cayman Islands developed WN virus encephalitis [<a href="#rid38">38</a>]. By 2003, the virus was detected in El Salvador, Guatemala, and Belize [<a href="#rid39">39</a>]; by 2004 in Colombia and Venezuela [<a href="#rid40">40</a>]; and by 2005 in Argentina [<a href="#rid41">41</a>]. </p><p>However, isolation of virus has been infrequent and documented avian, equine, and human morbidity are scant [<a href="#rid42">42,43</a>]. Documented human infections have been limited to a few patients in the Cayman Islands [<a href="#rid38">38</a>], Cuba [<a href="#rid44">44</a>], Haiti [<a href="#rid45">45</a>], Puerto Rico [<a href="#rid46">46</a>], northern Mexico [<a href="#rid47">47</a>], and Brazil [<a href="#rid48">48</a>].</p><p>The reasons for the discrepancy between the serologic evidence indicating widespread WN virus circulation in the Caribbean, Central and South America, and Mexico and the lack of substantial avian, equine, or human morbidity remain a mystery.</p><p class="headingAnchor" id="H2444095245"><span class="h2">Incidence in other countries</span><span class="headingEndMark"> — </span>From the 1960s through the 1980s, WN virus was isolated infrequently from mosquitoes, birds, horses, and humans in southern Europe. The first large human outbreak in Europe occurred in Romania in 1996 [<a href="#rid14">14</a>]. Since that time, outbreaks and sporadic human cases have occurred in an expanding area roughly extending from Spain, Italy, Greece, through the Balkans, Ukraine, and the Russian Federation (Volgograd, Astrakchan, and Rostov) [<a href="#rid49">49</a>]. From 2010 to 2018, 110 to 991 neuroinvasive disease cases were reported in European Union countries [<a href="#rid50">50</a>]. The largest outbreak occurred in 2018 with 991 human cases, a total exceeding the previous seven years combined. Among European Union countries, Greece, Italy, and Romania have reported the most cases. Cases and outbreaks also frequently occur in Israel.</p><p class="headingAnchor" id="H7"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Nearly all human infections with WN virus are due to mosquito bites. Birds are the primary amplifying hosts, and the virus is maintained in a bird-mosquito-bird cycle. Humans, horses, and many other vertebrates serve as incidental hosts and are not felt to be important for transmission since viremia is both short-lived and low-grade [<a href="#rid51">51,52</a>].</p><p>Rarely, transmission can also occur from mother to child in utero, or from an infected donor to a blood or organ transplant recipient. Transmission has also been documented via breast milk [<a href="#rid53">53</a>], occupational percutaneous exposure [<a href="#rid54">54</a>], conjunctival exposure [<a href="#rid55">55</a>], and by unidentified means in a dialysis center [<a href="#rid56">56</a>]. </p><p class="headingAnchor" id="H1117177544"><span class="h3">Mosquitoes</span><span class="headingEndMark"> — </span>Mosquitos that transmit WN virus are usually of the <em>Culex</em> species, which vary by geographic area. The major mosquito vectors in Africa and the Middle East are <em>Culex univittatus</em> and <em>Culex pipiens molestus</em>, and in Asia, <em>Culex tritaeniorhynchus</em>. WN virus has been recovered from ticks in Russia, but it is not clear what role they play in maintaining or disseminating the virus.</p><p>Surveillance has identified 66 mosquito species infected with the WN virus in North America. WN and the St. Louis encephalitis viruses appear to share the same maintenance vectors (see  <a class="medical medical_review" href="/z/d/html/1288.html" rel="external">"St. Louis encephalitis"</a>). <em>Culex pipiens</em> (northern house mosquito) is an important maintenance vector in the northern United States and Canada, <em>Culex pipiens quinquefasciatus</em> (southern house mosquito) is important in the southern United States, and <em>Culex tarsalis</em> is important in the western United States and Canada [<a href="#rid57">57</a>]. </p><p class="headingAnchor" id="H8"><span class="h4">Birds as amplifying hosts</span><span class="headingEndMark"> — </span>Numerous passerine birds develop prolonged high levels of viremia and serve as amplifying hosts. In many countries, the birds remain asymptomatic [<a href="#rid58">58,59</a>]. As an example, avian WN virus mortality in Europe is uncommon, presumably due to long standing coevolution of viruses and hosts following introduction by virus-infected migratory birds from Africa. </p><p>By contrast, significant avian mortality has been noted in Israel, the United States, and Canada, where similar strains of the virus have circulated [<a href="#rid9">9,60</a>]. High mortality has been noted among American crows and other North American corvids (ravens, jays, and other crows) [<a href="#rid61">61</a>]. Decreases in populations of American crows have been sustained, and impacts on other species mostly have recovered to previous abundances [<a href="#rid62">62</a>]. Single nucleotide changes in the NS1-2B and NS3 genes appear responsible for the increased mortality in American crows [<a href="#rid58">58,63,64</a>].</p><p>In the early years following the spread of WN in the United States, a higher incidence of WN infection was noted to occur in residents who live in high crow-mortality areas compared with those who reside outside of these areas [<a href="#rid65">65</a>]. However, decreasing susceptible bird populations and waning interest in avian mortality surveillance have decreased the value of dead crow sightings as an indicator of virus activity. </p><p class="headingAnchor" id="H1117177487"><span class="h3">Donated blood</span><span class="headingEndMark"> — </span>Transmission has been described via transfused blood, red blood cells, platelets, and fresh frozen plasma [<a href="#rid66">66</a>]. However, universal screening of the United States and Canadian blood supplies has nearly eliminated the risk of transfusion-transmitted WN virus infection [<a href="#rid52">52,67,68</a>]. Nevertheless, a small residual risk remains from donations with low viremia not detected by nucleic acid testing (NAT) in the minipool or individual donation format used by blood centers [<a href="#rid69">69-71</a>]. (See  <a class="medical medical_review" href="/z/d/html/7946.html" rel="external">"Blood donor screening: Laboratory testing", section on 'West Nile virus'</a>.) </p><p class="headingAnchor" id="H1117177493"><span class="h3">Organ transplant</span><span class="headingEndMark"> — </span>In 2002, transmission via donated organs was first documented when four recipients of organs from a common donor developed WN virus infection [<a href="#rid72">72</a>]. Serum from the day of organ harvest was positive for WN virus by NAT and culture. A second transmission occurred in 2005 in which three of four organ recipients developed WN virus infection [<a href="#rid73">73</a>]. Since then, additional transmission clusters have been published in the United States [<a href="#rid74">74-76</a>] and one in Italy, all from deceased donors [<a href="#rid77">77</a>]. Serum from the donors in several clusters were negative for WN virus RNA, suggesting that transmission can occur from virus sequestered in organs in the absence of detectable viremia in serum.</p><p class="headingAnchor" id="H1117177512"><span class="h3">Transplacental</span><span class="headingEndMark"> — </span>Transplacental transmission of WN virus can occur [<a href="#rid78">78,79</a>]. In 2002, for example, a case of congenital infection following second trimester infection in the mother was reported [<a href="#rid79">79</a>]. In addition, the CDC registry tracked pregnancies from 2003 to 2004 and identified 77 women infected with WN virus in 16 states [<a href="#rid78">78</a>]. Of the 72 infants followed, three infants (4 percent) had symptomatic WN virus disease at or shortly after birth. These infants were born to women who had developed symptomatic WN virus infection within three weeks of delivery. Although cord blood or infant serum at the time of delivery were not available, intrauterine infection or infection at the time of delivery was possible.</p><p>However, transmission appears to be rare. A retrospective study among 549 infants born after a community-wide epidemic of WN virus examined the relationship between birth outcomes and possible exposure to WN virus during pregnancy [<a href="#rid80">80</a>]. Cord blood samples looking for immunoglobulin M (IgM) antibodies to WN virus provided no evidence of congenital WN virus infections, and there were no significant clinical differences between infants of exposed and unexposed mothers.</p><p class="headingAnchor" id="H10"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of severe infection with WN virus is not well understood.</p><p class="headingAnchor" id="H11"><span class="h2">Dissemination</span><span class="headingEndMark"> — </span>During feeding, the mosquito injects virus-laden saliva into the host. Dissemination of WN virus following subcutaneous inoculation can be described in three phases: early phase (replication in keratinocytes and skin-resident dendritic cells, including dermal dendritic cells and Langerhans cells), visceral-organ dissemination phase (viral replication in the draining lymph nodes, and viremia and spread to visceral organs, including the spleen) and central nervous system (CNS) phase (invasion of the CNS) [<a href="#rid81">81</a>]. </p><p>In mouse models, the primary viremia is cleared in approximately one week, at which time virus levels in the CNS increase and neurological manifestations appear [<a href="#rid82">82</a>]. The mechanisms by which WN virus enters the CNS are not precisely known, but likely include [<a href="#rid83">83-86</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Direct viral crossing of the blood-brain barrier due to cytokine-mediated increased vascular permeability</p><p class="bulletIndent1"><span class="glyph">●</span>Infection or passive transport through endothelium or choroid plexus epithelial cells</p><p class="bulletIndent1"><span class="glyph">●</span>Trafficking of infected tissue macrophages across the blood-brain barrier</p><p class="bulletIndent1"><span class="glyph">●</span>Infection of olfactory neurons</p><p class="bulletIndent1"><span class="glyph">●</span>Direct axonal retrograde transport from infected olfactory or peripheral neurons</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Humoral immunity</span><span class="headingEndMark"> — </span>As with other flaviviruses, humoral immunity is critical for protection from WN virus. As an example, mice genetically deficient in B cells had increased WN viral loads in the CNS, and the infection was lethal at lower doses of virus compared with controls [<a href="#rid87">87</a>]. In addition, the presence of neutralizing antibody correlates with protection from flaviviruses, and passive transfer of IgG antibody can protect against WN challenge [<a href="#rid88">88</a>]. (See  <a class="medical medical_review" href="/z/d/html/1282.html" rel="external">"Treatment and prevention of West Nile virus infection", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Cell intrinsic innate immunity</span><span class="headingEndMark"> — </span>Innate antiviral defenses are also critical for control of WN virus, as demonstrated in mouse models and evidenced by extreme susceptibility to infection in persons with certain immunocompromising conditions. These innate defenses include the production of type I interferons and proinflammatory cytokines, the expression of antiviral genes, and the subsequent activation of the adaptive immune response [<a href="#rid81">81,83,89-93</a>]. WN virus infection is sensed by pattern-recognition receptors, including retinoic acid-inducible gene 1 protein (RIG-1)-like receptors and Toll-like receptors, which recognize distinct viral signatures known as pathogen-associated molecular patterns. These receptors subsequently trigger downstream signaling pathways that activate the innate immune defenses, including the production of interferons-alpha/beta. Interferons-alpha/beta subsequently stimulate genes that inhibit viral replication, modulate the adaptive immune response, and possibly tighten the blood-brain barrier to limit neuroinvasion [<a href="#rid90">90</a>]. </p><p class="headingAnchor" id="H15"><span class="h2">Complement</span><span class="headingEndMark"> — </span>The complement system is a large family of proteins that recognize pathogen-associated molecular patterns, altered cell surface ligands, and immune complexes. Complement suppresses WN viral infection by inducing several antiviral effector functions of the immune response [<a href="#rid81">81</a>], and has been demonstrated to prevent lethal WN infection in mice [<a href="#rid83">83</a>].</p><p>However, WN virus may evade complement-mediated control via its nonstructural protein (NS)-1. NS-1 binds and recruits the complement regulatory protein factor H, which may lower the ability of the immune system to target WN virus by decreasing complement-mediated recognition of infected cells [<a href="#rid94">94</a>].</p><p class="headingAnchor" id="H16"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Histological findings in WN neuroinvasive disease include microglial nodules with variable loss of neurons, perivascular cuffing by mononuclear cells, and neuronophagia [<a href="#rid95">95</a>]. The most impacted areas of the central nervous system (CNS) include the medulla, pons, thalamus, and substantia nigra of the basal ganglia. In the spinal cord, involvement of the anterior horns and anterior spinal nerve roots lead to lower motor neuron loss [<a href="#rid75">75,95</a>]. </p><p class="headingAnchor" id="H18"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/4001.html" rel="external">"Patient education: West Nile virus infection (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – West Nile (WN) virus is one of the most widely distributed of all arboviruses with an extensive distribution in the Old World, throughout Africa, the Middle East, parts of Europe and the former Soviet Union, South Asia, and Australia. The virus had not been detected in North America before the 1999 New York City outbreak. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – Nearly all human infections with WN virus are due to mosquito bites. Birds are the primary amplifying hosts, and the virus is maintained in a bird-mosquito-bird cycle. Mosquitoes that transmit WN virus are usually of the <em>Culex</em> species, which vary by geographic area. Other less common routes include transfused blood and transplanted organs. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Humoral immunity, cell intrinsic innate immunity, and the complement system all contribute to the host’s ability to prevent severe WN virus infection. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology</strong> – Histological findings in WN neuroinvasive disease include microglial nodules with variable loss of neurons, perivascular cuffing by mononuclear cells, and neuronophagia. (See <a class="local">'Pathology'</a> above.) </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Smithburn K, Hughes T, Burke A, et al. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940; 20:471.</a></li><li><a class="nounderline abstract_t">Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007; 45:1039.</a></li><li><a class="nounderline abstract_t">Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807.</a></li><li><a class="nounderline abstract_t">Petersen LR. Epidemiology of West Nile Virus in the United States: Implications for Arbovirology and Public Health. J Med Entomol 2019; 56:1456.</a></li><li><a class="nounderline abstract_t">Chancey C, Grinev A, Volkova E, Rios M. The global ecology and epidemiology of West Nile virus. Biomed Res Int 2015; 2015:376230.</a></li><li><a class="nounderline abstract_t">Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286:2333.</a></li><li><a class="nounderline abstract_t">Giladi M, Metzkor-Cotter E, Martin DA, et al. West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis 2001; 7:659.</a></li><li><a class="nounderline abstract_t">May FJ, Davis CT, Tesh RB, Barrett AD. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol 2011; 85:2964.</a></li><li><a class="nounderline abstract_t">Petersen LR, Roehrig JT. West Nile virus: a reemerging global pathogen. Emerg Infect Dis 2001; 7:611.</a></li><li><a class="nounderline abstract_t">Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004; 23:147.</a></li><li><a class="nounderline abstract_t">Murgue B, Murri S, Triki H, et al. West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci 2001; 951:117.</a></li><li><a class="nounderline abstract_t">Jupp PG. The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans. Ann N Y Acad Sci 2001; 951:143.</a></li><li><a class="nounderline abstract_t">McIntosh BM, Jupp PG, Dos Santos I, et al. Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobold as vector. S Afr J Sci 1970; 72:295.</a></li><li><a class="nounderline abstract_t">Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352:767.</a></li><li><a class="nounderline abstract_t">Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7:675.</a></li><li><a class="nounderline abstract_t">Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 2001; 7:128.</a></li><li><a class="nounderline abstract_t">Drebot MA, Lindsay R, Barker IK, et al. West Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis 2003; 14:105.</a></li><li><a class="nounderline abstract_t">Danis K, Papa A, Papanikolaou E, et al. Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. Euro Surveill 2011; 16.</a></li><li><a class="nounderline abstract_t">Anukumar B, Sapkal GN, Tandale BV, et al. West Nile encephalitis outbreak in Kerala, India, 2011. J Clin Virol 2014; 61:152.</a></li><li><a class="nounderline abstract_t">Rizzo C, Napoli C, Venturi G, et al. West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015. Euro Surveill 2016; 21.</a></li><li><a class="nounderline abstract_t">Rizzoli A, Jimenez-Clavero MA, Barzon L, et al. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill 2015; 20.</a></li><li><a class="nounderline abstract_t">Zehender G, Veo C, Ebranati E, et al. Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography. PLoS One 2017; 12:e0179679.</a></li><li><a class="nounderline abstract_t">Marini G, Calzolari M, Angelini P, et al. A quantitative comparison of West Nile virus incidence from 2013 to 2018 in Emilia-Romagna, Italy. PLoS Negl Trop Dis 2020; 14:e0007953.</a></li><li><a class="nounderline abstract_t">McDonald E, Martin SW, Landry K, et al. West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases - United States, 2018. MMWR Morb Mortal Wkly Rep 2019; 68:673.</a></li><li><a class="nounderline abstract_t">Hahn MB, Monaghan AJ, Hayden MH, et al. Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012. Am J Trop Med Hyg 2015; 92:1013.</a></li><li><a class="nounderline abstract_t">Shand L, Brown WM, Chaves LF, et al. Predicting West Nile Virus Infection Risk From the Synergistic Effects of Rainfall and Temperature. J Med Entomol 2016; 53:935.</a></li><li><a class="nounderline abstract_t">Petersen LR, Hayes EB. West Nile virus in the Americas. Med Clin North Am 2008; 92:1307.</a></li><li class="breakAll">Centers for Disease Control and Prevention. West Nile virus: Final Cumulative Maps &amp; Data for 1999–2018. https://www.cdc.gov/westnile/statsmaps/cumMapsData.html (Accessed on February 19, 2020).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). West Nile virus and other arboviral diseases--United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:513.</a></li><li><a class="nounderline abstract_t">Chung WM, Buseman CM, Joyner SN, et al. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013; 310:297.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. West Nile Virus Disease Cases by State 2021. https://www.cdc.gov/westnile/statsmaps/preliminarymapsdata2021/disease-cases-state-2021.html (Accessed on December 06, 2021).</li><li><a class="nounderline abstract_t">Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Serosurveys for West Nile virus infection--New York and Connecticut counties, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:37.</a></li><li><a class="nounderline abstract_t">Busch MP, Wright DJ, Custer B, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 2006; 12:395.</a></li><li><a class="nounderline abstract_t">Williamson PC, Custer B, Biggerstaff BJ, et al. Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic. Epidemiol Infect 2017; 145:2536.</a></li><li><a class="nounderline abstract_t">Schellenberg TL, Anderson ME, Drebot MA, et al. Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health 2006; 97:369.</a></li><li class="breakAll">Government of Canada. Surveillance of West Nile virus. https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/surveillance-west-nile-virus.html (Accessed on November 24, 2021).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). West Nile Virus activity--United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:497.</a></li><li><a class="nounderline abstract_t">Cruz L, Cardenas VM, Abarca M, et al. Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg 2005; 72:612.</a></li><li><a class="nounderline abstract_t">Mattar S, Edwards E, Laguado J, et al. West Nile virus antibodies in Colombian horses. Emerg Infect Dis 2005; 11:1497.</a></li><li><a class="nounderline abstract_t">Adrián Diaz L, Komar N, Visintin A, et al. West Nile virus in birds, Argentina. Emerg Infect Dis 2008; 14:689.</a></li><li><a class="nounderline abstract_t">Morales MA, Barrandeguy M, Fabbri C, et al. West Nile virus isolation from equines in Argentina, 2006. Emerg Infect Dis 2006; 12:1559.</a></li><li><a class="nounderline abstract_t">Estrada-Franco JG, Navarro-Lopez R, Beasley DW, et al. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis 2003; 9:1604.</a></li><li><a class="nounderline abstract_t">Pupo M, Guzmán MG, Fernández R, et al. West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis 2006; 12:1022.</a></li><li><a class="nounderline abstract_t">Beatty ME, Hunsperger E, Long E, et al. Mosquitoborne infections after Hurricane Jeanne, Haiti, 2004. Emerg Infect Dis 2007; 13:308.</a></li><li><a class="nounderline abstract_t">Hunsperger EA, McElroy KL, Bessoff K, et al. West Nile virus from blood donors, vertebrates, and mosquitoes, Puerto Rico, 2007. Emerg Infect Dis 2009; 15:1298.</a></li><li><a class="nounderline abstract_t">Elizondo-Quiroga D, Davis CT, Fernandez-Salas I, et al. West Nile Virus isolation in human and mosquitoes, Mexico. Emerg Infect Dis 2005; 11:1449.</a></li><li><a class="nounderline abstract_t">Vieira MA, Romano AP, Borba AS, et al. West Nile Virus Encephalitis: The First Human Case Recorded in Brazil. Am J Trop Med Hyg 2015; 93:377.</a></li><li><a class="nounderline abstract_t">Bakonyi T, Haussig JM. West Nile virus keeps on moving up in Europe. Euro Surveill 2020; 25.</a></li><li><a class="nounderline abstract_t">Young JJ, Haussig JM, Aberle SW, et al. Epidemiology of human West Nile virus infections in the European Union and European Union enlargement countries, 2010 to 2018. Euro Surveill 2021; 26.</a></li><li><a class="nounderline abstract_t">Bunning ML, Bowen RA, Cropp CB, et al. Experimental infection of horses with West Nile virus. Emerg Infect Dis 2002; 8:380.</a></li><li><a class="nounderline abstract_t">Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353:460.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:877.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Laboratory-acquired West Nile virus infections--United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1133.</a></li><li><a class="nounderline abstract_t">Fonseca K, Prince GD, Bratvold J, et al. West Nile virus infection and conjunctival exposure. Emerg Infect Dis 2005; 11:1648.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Possible dialysis-related west nile virus transmission--Georgia, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:738.</a></li><li><a class="nounderline abstract_t">Rochlin I, Faraji A, Healy K, Andreadis TG. West Nile Virus Mosquito Vectors in North America. J Med Entomol 2019; 56:1475.</a></li><li><a class="nounderline abstract_t">Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 2003; 9:311.</a></li><li><a class="nounderline abstract_t">Komar O, Robbins MB, Klenk K, et al. West Nile virus transmission in resident birds, Dominican Republic. Emerg Infect Dis 2003; 9:1299.</a></li><li><a class="nounderline abstract_t">Swayne DE, Beck JR, Smith CS, et al. Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis 2001; 7:751.</a></li><li><a class="nounderline abstract_t">LaDeau SL, Kilpatrick AM, Marra PP. West Nile virus emergence and large-scale declines of North American bird populations. Nature 2007; 447:710.</a></li><li><a class="nounderline abstract_t">Kilpatrick AM, Wheeler SS. Impact of West Nile Virus on Bird Populations: Limited Lasting Effects, Evidence for Recovery, and Gaps in Our Understanding of Impacts on Ecosystems. J Med Entomol 2019; 56:1491.</a></li><li><a class="nounderline abstract_t">Brault AC, Huang CY, Langevin SA, et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet 2007; 39:1162.</a></li><li><a class="nounderline abstract_t">Dietrich EA, Langevin SA, Huang CY, et al. West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms. PLoS Negl Trop Dis 2016; 10:e0004938.</a></li><li><a class="nounderline abstract_t">Watson JT, Jones RC, Gibbs K, Paul W. Dead crow reports and location of human West Nile virus cases, Chicago, 2002. Emerg Infect Dis 2004; 10:938.</a></li><li><a class="nounderline abstract_t">Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236.</a></li><li><a class="nounderline abstract_t">Petersen LR, Epstein JS. Problem solved? West Nile virus and transfusion safety. N Engl J Med 2005; 353:516.</a></li><li><a class="nounderline abstract_t">Dodd RY, Foster GA, Stramer SL. Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012. Transfus Med Rev 2015; 29:153.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). West Nile virus transmission through blood transfusion--South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:76.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Fatal West Nile virus infection after probable transfusion-associated transmission--Colorado, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:622.</a></li><li><a class="nounderline abstract_t">Groves JA, Shafi H, Nomura JH, et al. A probable case of West Nile virus transfusion transmission. Transfusion 2017; 57:850.</a></li><li><a class="nounderline abstract_t">Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). West Nile virus infections in organ transplant recipients--New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1021.</a></li><li><a class="nounderline abstract_t">Nett RJ, Kuehnert MJ, Ison MG, et al. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 2012; 14:268.</a></li><li><a class="nounderline abstract_t">Winston DJ, Vikram HR, Rabe IB, et al. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation 2014; 97:881.</a></li><li><a class="nounderline abstract_t">Yango AF, Fischbach BV, Levy M, et al. West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic. Transplantation 2014; 97:953.</a></li><li><a class="nounderline abstract_t">Inojosa WO, Scotton PG, Fuser R, et al. West Nile virus transmission through organ transplantation in north-eastern Italy: a case report and implications for pre-procurement screening. Infection 2012; 40:557.</a></li><li><a class="nounderline abstract_t">O'Leary DR, Kuhn S, Kniss KL, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006; 117:e537.</a></li><li><a class="nounderline abstract_t">Nguyen Q, Teran S, Snedeker J, et al. CNS sequelae in an infant with congenital West Nile virus infection. Infect Med 2005; 22:626.</a></li><li><a class="nounderline abstract_t">Paisley JE, Hinckley AF, O'Leary DR, et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics 2006; 117:814.</a></li><li><a class="nounderline abstract_t">Suthar MS, Diamond MS, Gale M Jr. West Nile virus infection and immunity. Nat Rev Microbiol 2013; 11:115.</a></li><li><a class="nounderline abstract_t">Gea-Banacloche J, Johnson RT, Bagic A, et al. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 2004; 140:545.</a></li><li><a class="nounderline abstract_t">Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 2006; 80:9349.</a></li><li><a class="nounderline abstract_t">Samuel MA, Wang H, Siddharthan V, et al. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A 2007; 104:17140.</a></li><li><a class="nounderline abstract_t">Winkelmann ER, Luo H, Wang T. West Nile Virus Infection in the Central Nervous System. F1000Res 2016; 5.</a></li><li><a class="nounderline abstract_t">Bai F, Thompson EA, Vig PJS, Leis AA. Current Understanding of West Nile Virus Clinical Manifestations, Immune Responses, Neuroinvasion, and Immunotherapeutic Implications. Pathogens 2019; 8.</a></li><li><a class="nounderline abstract_t">Diamond MS, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003; 77:2578.</a></li><li><a class="nounderline abstract_t">Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003; 188:1.</a></li><li><a class="nounderline abstract_t">Lazear HM, Diamond MS. New insights into innate immune restriction of West Nile virus infection. Curr Opin Virol 2015; 11:1.</a></li><li><a class="nounderline abstract_t">Daniels BP, Holman DW, Cruz-Orengo L, et al. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio 2014; 5:e01476.</a></li><li><a class="nounderline abstract_t">Tobler LH, Cameron MJ, Lanteri MC, et al. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis 2008; 198:979.</a></li><li><a class="nounderline abstract_t">Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 2005; 79:13350.</a></li><li><a class="nounderline abstract_t">Shrestha B, Wang T, Samuel MA, et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 2006; 80:5338.</a></li><li><a class="nounderline abstract_t">Chung KM, Liszewski MK, Nybakken G, et al. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A 2006; 103:19111.</a></li><li><a class="nounderline abstract_t">Bouffard JP, Riudavets MA, Holman R, Rushing EJ. Neuropathology of the brain and spinal cord in human West Nile virus infection. Clin Neuropathol 2004; 23:59.</a></li></ol></div><div id="topicVersionRevision">Topic 1304 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A neurotropic virus isolated from the blood of a native of Uganda</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17879923" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The continuing spread of West Nile virus in the western hemisphere.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11407341" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The outbreak of West Nile virus infection in the New York City area in 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31549728" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epidemiology of West Nile Virus in the United States: Implications for Arbovirology and Public Health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25866777" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The global ecology and epidemiology of West Nile virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10600742" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11585528" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : West Nile encephalitis in Israel, 1999: the New York connection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21159871" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11585520" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : West Nile virus: a reemerging global pathogen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14986160" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11797769" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : West Nile in the Mediterranean basin: 1950-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11797772" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobold as vector</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9737281" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : West Nile encephalitis epidemic in southeastern Romania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11585531" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Clinical characteristics of the West Nile fever outbreak, Israel, 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11266303" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18159433" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : West Nile virus surveillance and diagnostics: A Canadian perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21903037" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24985196" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : West Nile encephalitis outbreak in Kerala, India, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27684046" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26027485" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The challenge of West Nile virus in Europe: knowledge gaps and research priorities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28678837" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31895933" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A quantitative comparison of West Nile virus incidence from 2013 to 2018 in Emilia-Romagna, Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31393865" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases - United States, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25802435" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27113111" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Predicting West Nile Virus Infection Risk From the Synergistic Effects of Rainfall and Temperature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19145778" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : West Nile virus in the Americas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19145778" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : West Nile virus in the Americas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23803959" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : West Nile virus and other arboviral diseases--United States, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23860988" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The 2012 West Nile encephalitis epidemic in Dallas, Texas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23860988" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The 2012 West Nile encephalitis epidemic in Dallas, Texas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11498211" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11215880" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Serosurveys for West Nile virus infection--New York and Connecticut counties, 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16704775" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : West Nile virus infections projected from blood donor screening data, United States, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26829991" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17120874" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17120874" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12079245" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : West Nile Virus activity--United States, 2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15891137" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Short report: serological evidence of West Nile virus activity in El Salvador.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16673523" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : West Nile virus antibodies in Colombian horses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18394305" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : West Nile virus in birds, Argentina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17176571" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : West Nile virus isolation from equines in Argentina, 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14720402" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : West Nile virus in Mexico: evidence of widespread circulation since July 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16707068" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : West Nile Virus infection in humans and horses, Cuba.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17479899" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Mosquitoborne infections after Hurricane Jeanne, Haiti, 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19751597" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : West Nile virus from blood donors, vertebrates, and mosquitoes, Puerto Rico, 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16229779" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : West Nile Virus isolation in human and mosquitoes, Mexico.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26055749" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : West Nile Virus Encephalitis: The First Human Case Recorded in Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33213684" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : West Nile virus keeps on moving up in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33988124" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Epidemiology of human West Nile virus infections in the European Union and European Union enlargement countries, 2010 to 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11971771" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Experimental infection of horses with West Nile virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16079369" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12375687" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12537288" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Laboratory-acquired West Nile virus infections--United States, 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16355512" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : West Nile virus infection and conjunctival exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15318158" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Possible dialysis-related west nile virus transmission--Georgia, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31549725" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : West Nile Virus Mosquito Vectors in North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12643825" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Experimental infection of North American birds with the New York 1999 strain of West Nile virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609467" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : West Nile virus transmission in resident birds, Dominican Republic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11585545" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17507930" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : West Nile virus emergence and large-scale declines of North American bird populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31549723" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Impact of West Nile Virus on Bird Populations: Limited Lasting Effects, Evidence for Recovery, and Gaps in Our Understanding of Impacts on Ecosystems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694056" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A single positively selected West Nile viral mutation confers increased virogenesis in American crows.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27548738" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15200837" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Dead crow reports and location of human West Nile virus cases, Chicago, 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14500806" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Transmission of West Nile virus through blood transfusion in the United States in 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16079376" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Problem solved? West Nile virus and transfusion safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25841631" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17268405" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : West Nile virus transmission through blood transfusion--South Dakota, 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23925171" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Fatal West Nile virus infection after probable transfusion-associated transmission--Colorado, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28164314" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A probable case of West Nile virus transfusion transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12773646" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Transmission of West Nile virus from an organ donor to four transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16224451" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : West Nile virus infections in organ transplant recipients--New York and Pennsylvania, August-September, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22606990" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Current practices and evaluation of screening solid organ donors for West Nile virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24827763" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24827765" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22544764" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : West Nile virus transmission through organ transplantation in north-eastern Italy: a case report and implications for pre-procurement screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16510632" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : CNS sequelae in an infant with congenital West Nile virus infection</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16510662" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23321534" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : West Nile virus infection and immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15068983" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : West Nile virus: pathogenesis and therapeutic options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16973541" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17939996" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26918172" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : West Nile Virus Infection in the Central Nervous System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31623175" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Current Understanding of West Nile Virus Clinical Manifestations, Immune Responses, Neuroinvasion, and Immunotherapeutic Implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12551996" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12825164" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Human immunoglobulin as a treatment for West Nile virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25554924" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : New insights into innate immune restriction of West Nile virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25161189" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18729779" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16227257" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16699014" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17132743" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15074579" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Neuropathology of the brain and spinal cord in human West Nile virus infection.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
